$76.23
2.543.45%
Last update: Aug 25, 9:41 AM
Nektar Therapeutics Earnings Estimates
NKTRNASDAQ
Nektar Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:NKTR
Nektar Therapeutics (NKTR) is scheduled to report Q3 earnings on November 5, 2026. Analysts estimate EPS of $-2.27 and quarterly revenue of $10.38M.
In the most recent quarter (Q2), Nektar Therapeutics reported EPS of $-1.23, beating estimates of $-2.04 by 0.4%. Revenue came in at $10.13M, missing the estimate of $10.54M by 0.04%.
Over the last 4 quarters, Nektar Therapeutics has averaged an EPS surprise of 0.34% and a revenue surprise of 0.34%.
Earnings Date
Nov 5
EPS Estimate
$-2.270
Quarterly Revenue Estimate
$10.38M
Annual Revenue
$54.59M
as of Jun 30
Nektar Therapeutics Earnings History
Analyze the earnings history of Nektar Therapeutics using advanced sorting and filters.
Nektar Therapeutics (NKTR) Earnings Per Share
The chart below shows Nektar Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Nektar Therapeutics (NKTR) Revenue
The chart below shows Nektar Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?
Nektar Therapeutics (NKTR) is scheduled to report earnings on November 5, 2026. The last reported earnings were for reported on August 13, 2026 for Q2.
What were the latest earnings per share (EPS) for Nektar Therapeutics (NASDAQ:NKTR)?
The Actual EPS was $-1.23, which beat the estimate of $-2.04.
What were Nektar Therapeutics’s (NASDAQ:NKTR) revenues?
The Actual Revenue was $10.13M, which missed the estimate of $10.54M.
